Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPACOMT: Long-term ulipristal acetate in Charcot-Marie-Tooth disease type 1A
2015-001716-36Phase 2Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ulipristal in Charcot-Marie-Tooth disease type 1A (CMT1A) and Charcot-Marie-Tooth disease (CMT), sponsored by Strasbourg University Hospital. Started Jun 2015; status: completed.
02
Drugs
ulipristal
03
Conditions
Charcot-Marie-Tooth disease type 1A (CMT1A)Charcot-Marie-Tooth disease (CMT)
Beyond the preview
Go deeper on 2015-001716-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001716-36.